z-logo
Premium
Improving basic and membrane protein MS detection of the culture filtrate proteins from Mycobacterium tuberculosis H37Rv by biomimetic affinity prefractionation
Author(s) -
Ma Guorong,
Zhang Kang,
Zhou Fuqiang,
Gao Lina,
Sun Zhanqiang,
Deng Li,
Zhang Shulin,
Li Rongxiu
Publication year - 2017
Publication title -
proteomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.26
H-Index - 167
eISSN - 1615-9861
pISSN - 1615-9853
DOI - 10.1002/pmic.201600177
Subject(s) - proteome , mycobacterium tuberculosis , affinity chromatography , membrane protein , chromatography , chemistry , transmembrane protein , proteomics , tuberculosis , computational biology , biochemistry , membrane , biology , receptor , enzyme , medicine , pathology , gene
The culture filtrate proteins (CFPs) from Mycobacterium tuberculosis have been shown to induce protective immune responses in human and animal models, making them a promising source of candidate targets for tuberculosis drugs, vaccines, and diagnostics. The constituents of the M. tuberculosis CFP proteome are complex and vary with growth conditions. To effectively profile CFPs, gel‐based prefractionation is usually performed before MS analysis. In this study, we describe a novel prefractionation approach by which the proteome is divided into seven partially overlapping fractions by biomimetic affinity chromatography (BiAC) using a six‐column cascade. The LC‐MS/MS analysis of individual fractions identified a total of 541 CFPs, including 61 first‐time identifications. Notably, ∼1/3 (20/61) of these novel CFPs are membrane proteins, among which nine proteins have 2–14 transmembrane domains. In addition, ∼1/4 (14/61) of the CFPs are basic proteins with p I values greater than 9.0. Our data demonstrate that biomimetic affinity chromatography prefractionation markedly improves protein detection by LC‐MS/MS, and the coverage of basic and hydrophobic proteins in particular is remarkably increased.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here